Thor Medical ASA (FRA:8NN)

Germany flag Germany · Delayed Price · Currency is EUR
0.4095
+0.0055 (1.36%)
Last updated: Jan 21, 2026, 8:03 AM CET
88.28%
Market Cap150.70M +133.1%
Revenue (ttm)8.42K
Net Income-4.96M
EPS-0.02
Shares Outn/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volumen/a
Open0.4095
Previous Close0.4040
Day's Range0.4095 - 0.4095
52-Week Range0.1570 - 0.4500
Betan/a
RSI55.95
Earnings DateFeb 26, 2026

About Thor Medical ASA

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It develops Ra224, an isotope of radium; Pb-212, a radioactive isotope of lead; and Th-228, a radioactive isotope of thorium. The company was incorporated in 2009 and is headquartered in Oslo, Norway. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2009
Employees 13
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 8NN
Full Company Profile

Financial Performance

Financial numbers in NOK Financial Statements